In a chaotic meeting, ACIP voted not to recommend a prescription requirement for Covid-19 vaccines. Some panelists seemed ...

In a Q&A with STAT, Nobel winner Drew Weissman addressed concerns raised about Covid shots at a recent meeting of federal ...

In this Daily Rip Live clip, Shay Boloor tells Jordan why he’s excited about biotech and CRISPR names in his small-cap portfolio. 🧬 Shay owns Intellia ($NTLA), Beam ($BEAM), and Prime ($PRME), and ...

After swiftly developing its COVID-19 vaccine in 2020 and launching it late that year, Moderna soon found itself facing ...

From breakthroughs in artificial intelligence to revolutionary discoveries in medicine, the forces shaping tomorrow are being ...

Moderna (MRNA) and Alnylam (ALNY) resolve a patent dispute related to the technology used in former's COVID-19 vaccine. Read ...

Moderna has settled related lawsuits that accused it of misusing Alnylam Pharmaceuticals' patented technology in its COVID-19 ...

Genetic editing holds promise to treat incurable diseases, but the most popular method - CRISPR - sometimes does more harm ...

This year’s WIRED Health summit in Boston featured Moderna CEO Stéphane Bancel, CNN chief medical correspondent Sanjay Gupta, ...

The global antibody testing market is projected to grow at a CAGR of 6% from 2025 to 2030, driven by the rising prevalence of ...

The FDA approved 2025-2026 COVID vaccines from Pfizer (Comirnaty), Moderna (Spikevax, mNexspike), and Novavax (Nuvaxovid), the companies announced on Wednesday. But the agency removed one of the ...

Yesterday Pfizer and BioNTech reported phase 3 clinical trial data for their updated COVID vaccine, Comirnaty. That vaccine ...